Queen's University at Kingston

🇨🇦Canada

Country: 🇨🇦Canada

Ownership: Private

Established: 1841-10-16

Employees: 1K

Market Cap: -

Website: http://www.queensu.ca

Clinical Trials

Bone Enhanced Ultrasound (BEUS) Data Library Development Project

Not yet recruiting

Conditions: Lower Back Pain
Facet Joint Pain; Low Back Pain
Osteoarthritis (OA)

First Posted Date: 2025-06-25

Last Posted Date: 2025-06-27

Lead Sponsor: Queen's University

Target Recruit Count: 100

Registration Number: NCT07036653

Vaginal Estrogen for Improvement of Outcomes Following Pelvic Organ Prolapse Surgery

Phase 3

Not yet recruiting

Conditions: Pelvic Organ Prolapse (POP)

Interventions: Drug: Vaginal Estrogen - Twice Weekly
Drug: Vaginal Estrogen - Daily

First Posted Date: 2025-06-22

Last Posted Date: 2025-06-26

Lead Sponsor: Queen's University

Target Recruit Count: 180

Registration Number: NCT07030426

Locations: 🇨🇦
Health Sciences Centre, St John's, Newfoundland and Labrador, Canada
🇨🇦
Kingston Health Sciences Centre, Kingston, Ontario, Canada

Ketamine Assisted Psychotherapy for Treating Comorbid Chronic Pain and PTSD

Phase 1

Not yet recruiting

Conditions: Chronic Pain
Posttraumatic Stress Disorder (PTSD)

Interventions: Drug: Ketamine Infusion
Behavioral: Mindfulness-based cognitive therapy

First Posted Date: 2025-06-06

Last Posted Date: 2025-06-06

Lead Sponsor: Queen's University

Target Recruit Count: 30

Registration Number: NCT07009158

Does a Virtual Program for Pelvic Pain Improve Pain and Sexual Outcomes in Individuals With Provoked Vestibulodynia?

Not Applicable

Not yet recruiting

Conditions: Vulvodynia (Chronic Vulvar Pain)
Vulvar Vestibulitis
Vestibulodynia
Provoked Vestibulodynia
Provoked Localized Vulvodynia

First Posted Date: 2025-05-31

Last Posted Date: 2025-05-31

Lead Sponsor: Queen's University

Target Recruit Count: 250

Registration Number: NCT06999395

Safety, Tolerability, and Preliminary Efficacy of Psilocybin Oral Solution in Adults With Generalized Anxiety Disorder

Phase 2

Recruiting

Conditions: Generalized Anxiety Disorder (GAD)

Interventions: Drug: Psilocybin (drug)
Other: Placebo

First Posted Date: 2025-05-13

Last Posted Date: 2025-05-13

Lead Sponsor: Queen's University

Target Recruit Count: 50

Registration Number: NCT06969170

Locations: 🇨🇦
Kingston General Health Research Institute, Kingston, Ontario, Canada

Early Genomic Testing for Inherited Bleeding Disorders

Not Applicable

Not yet recruiting

Conditions: Bleeding Disorder

First Posted Date: 2025-03-25

Last Posted Date: 2025-03-26

Lead Sponsor: Kingston Health Sciences Centre

Target Recruit Count: 212

Registration Number: NCT06736158

Locations: 🇨🇦
Queen's University/Kingston Health Sciences Centre, Kingston, Ontario, Canada
🇨🇦
The Ottawa Hospital, Ottawa, Ontario, Canada
🇨🇦
Unity Health, Toronto, Ontario, Canada

STRIDE (durvalumab + Tremelimumab) with Lenvatinib Vs STRIDE Alone in Unresectable Hepatocellular Carcinoma

Phase 2

Not yet recruiting

Conditions: Hepatocellular Carcinoma

Interventions: Drug: STRIDE (durvalumab + tremelimumab)
Drug: Durvalumab
Drug: Lenvatinib

First Posted Date: 2025-03-17

Last Posted Date: 2025-03-17

Lead Sponsor: Canadian Cancer Trials Group

Target Recruit Count: 140

Registration Number: NCT06880523

Allergenic Extract Standardized Cat Hair AP in an Allergic Rhinitis Model.

Not Applicable

Recruiting

Conditions: Allergic Rhinitis

Interventions: Drug: Allergenic Extract Standardized Cat Hair Acetone-Precipitated (AP)

First Posted Date: 2025-02-14

Last Posted Date: 2025-03-10

Lead Sponsor: Queen's University

Target Recruit Count: 20

Registration Number: NCT06828484

Locations: 🇨🇦
Kingston Health Sciences Centre - Kingston General Hospital, Kingston, Ontario, Canada

A Probiotic Based Intervention in Pregnancies Complicated by GDM

Phase 2

Not yet recruiting

Conditions: Gestational Diabetes Mellitus (GDM)
Microbiome, Human

First Posted Date: 2025-01-27

Last Posted Date: 2025-06-06

Lead Sponsor: Queen's University

Target Recruit Count: 173

Registration Number: NCT06794723

Locations: 🇨🇦
Queen's University & Kingston Health Sciences Centre, Kingston, Ontario, Canada

Exploring Feasibility, Acceptability and Impact of Using Neurofeedback with Persons with Mild Cognitive Impairment

Not Applicable

Not yet recruiting

Conditions: Mild Cognitive Impairment

First Posted Date: 2025-01-07

Last Posted Date: 2025-01-07

Lead Sponsor: Queen's University

Target Recruit Count: 20

Registration Number: NCT06762522

Locations: 🇨🇦
Providence Care Hospital, Kingston, Ontario, Canada

AI-Powered Research

Premium Access

Queen's University at Kingston

Bone Enhanced Ultrasound (BEUS) Data Library Development Project

Vaginal Estrogen for Improvement of Outcomes Following Pelvic Organ Prolapse Surgery

Ketamine Assisted Psychotherapy for Treating Comorbid Chronic Pain and PTSD

Does a Virtual Program for Pelvic Pain Improve Pain and Sexual Outcomes in Individuals With Provoked Vestibulodynia?

Safety, Tolerability, and Preliminary Efficacy of Psilocybin Oral Solution in Adults With Generalized Anxiety Disorder

Early Genomic Testing for Inherited Bleeding Disorders

STRIDE (durvalumab + Tremelimumab) with Lenvatinib Vs STRIDE Alone in Unresectable Hepatocellular Carcinoma

Allergenic Extract Standardized Cat Hair AP in an Allergic Rhinitis Model.

A Probiotic Based Intervention in Pregnancies Complicated by GDM

Exploring Feasibility, Acceptability and Impact of Using Neurofeedback with Persons with Mild Cognitive Impairment